NM_001845.6:c.1728+57T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001845.6(COL4A1):c.1728+57T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.368 in 1,588,336 control chromosomes in the GnomAD database, including 108,981 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.39 ( 11633 hom., cov: 33)
Exomes 𝑓: 0.37 ( 97348 hom. )
Consequence
COL4A1
NM_001845.6 intron
NM_001845.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.20
Publications
12 publications found
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
- brain small vessel disease 1 with or without ocular anomaliesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
- autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
- microangiopathy and leukoencephalopathy, pontine, autosomal dominantInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pontine autosomal dominant microangiopathy with leukoencephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinal arterial tortuosityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 13-110187081-A-G is Benign according to our data. Variant chr13-110187081-A-G is described in ClinVar as Benign. ClinVar VariationId is 1293311.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.442 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL4A1 | NM_001845.6 | c.1728+57T>C | intron_variant | Intron 25 of 51 | ENST00000375820.10 | NP_001836.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.389 AC: 59119AN: 151826Hom.: 11611 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
59119
AN:
151826
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.366 AC: 525896AN: 1436390Hom.: 97348 AF XY: 0.365 AC XY: 261283AN XY: 716260 show subpopulations
GnomAD4 exome
AF:
AC:
525896
AN:
1436390
Hom.:
AF XY:
AC XY:
261283
AN XY:
716260
show subpopulations
African (AFR)
AF:
AC:
14845
AN:
33018
American (AMR)
AF:
AC:
18001
AN:
44604
Ashkenazi Jewish (ASJ)
AF:
AC:
7901
AN:
25984
East Asian (EAS)
AF:
AC:
17194
AN:
39572
South Asian (SAS)
AF:
AC:
28968
AN:
85658
European-Finnish (FIN)
AF:
AC:
18306
AN:
53100
Middle Eastern (MID)
AF:
AC:
1538
AN:
5670
European-Non Finnish (NFE)
AF:
AC:
397269
AN:
1089270
Other (OTH)
AF:
AC:
21874
AN:
59514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
17539
35079
52618
70158
87697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
12604
25208
37812
50416
63020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.390 AC: 59196AN: 151946Hom.: 11633 Cov.: 33 AF XY: 0.388 AC XY: 28799AN XY: 74274 show subpopulations
GnomAD4 genome
AF:
AC:
59196
AN:
151946
Hom.:
Cov.:
33
AF XY:
AC XY:
28799
AN XY:
74274
show subpopulations
African (AFR)
AF:
AC:
18552
AN:
41438
American (AMR)
AF:
AC:
5747
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1126
AN:
3466
East Asian (EAS)
AF:
AC:
2318
AN:
5142
South Asian (SAS)
AF:
AC:
1653
AN:
4814
European-Finnish (FIN)
AF:
AC:
3603
AN:
10570
Middle Eastern (MID)
AF:
AC:
85
AN:
292
European-Non Finnish (NFE)
AF:
AC:
24742
AN:
67928
Other (OTH)
AF:
AC:
816
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1869
3738
5606
7475
9344
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
574
1148
1722
2296
2870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1464
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.